ReviewDrug safety2013
Desideratum for evidence based epidemiology.
Review in Drug safety, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.Harvard data science review · 2020Article
- Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.Proceedings of the National Academy of Sciences of the United States of America · 2018Article
- Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.PloS one · 2016Article
- Comment on: "Desideratum for evidence-based epidemiology".Drug safety · 2015Article
- Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.Drug safety · 2013Article
- Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system.Drug safety · 2013Article
- The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.Drug safety · 2013Article
- Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.Drug safety · 2013Article
- Evaluation of disproportionality safety signaling applied to healthcare databases.Drug safety · 2013Article
- Moving along the yellow brick (card) road?Drug safety · 2013Article
- Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.Drug safety · 2013Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is great variation in choices of method and specific analytical details in epidemiological studies, resulting in widely varying results even when studying the same drug and outcome in the same database. Not only does this variation undermine the credibility of the research but it limits our ability to improve the methods.
methodsIn order to evaluate the performance of methods and analysis choices we used standard references and a literature review to identify 164 positive controls (drug-outcome pairs believed to represent true adverse drug reactions), and 234 negative controls (drug-outcome pairs for which we have confidence there is no direct causal relationship). We tested 3,748 unique analyses (methods in combination with specific analysis choices) that represent the full range of approaches to adjusting for confounding in five large observational datasets on these controls. We also evaluated the impact of increasingly specific outcome definitions, and performed a replication study in six additional datasets. We characterized the performance of each method using the area under the receiver operator curve (AUC), bias, and coverage probability. In addition, we developed simulated datasets that closely matched the characteristics of the observational datasets into which we inserted data consistent with known drug-outcome relationships in order to measure the accuracy of estimates generated by the analyses. DISCUSSION: We expect the results of this systematic, empirical evaluation of the performance of these analyses across a moderate range of outcomes and databases to provide important insights into the methods used in epidemiological studies and to increase the consistency with which methods are applied, thereby increasing the confidence in results and our ability to systematically improve our approaches.
Indexed as
Identifiers
24166219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.